FindTrial
Sign In

Pharmaceutical care services for diabetic foot ulcers

Impact of Pharmaceutical Care on Clinical, Economic, and Health-Related Quality of Life of Diabetic Foot Ulcer Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/029603
Enrollment
174
Registered
2020-12-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z00-Z99- Factors influencing health status and contact with health services

Interventions

Intervention1: Pharmaceutical Care group: Pharmaceutical Care group will receive the pharmaceutical care by the clinical pharmacist along with general care. PC group of patients will get the special

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients either of 3-foot complications: Peripheral vascular disease or Foot deformities or Abnormal plantar foot pressures Both inpatients and outpatients

Exclusion criteria

Exclusion criteria: Patients who are having psychiatric, other terminal illnesses and cognitive impairments. Trauma-related amputations patients Pregnant and lactating

Design outcomes

Primary

MeasureTime frame
Health-Related Quality of lifeTimepoint: Baseline, six and 12 months—

Secondary

MeasureTime frame
Clinical, Economic and Medication AdherenceTimepoint: Baseline, six and 12 months—

Countries

India

Contacts

Public ContactDr Barma Naga Raju

NGSM Institute of Pharmaceutical Sciences

udayvenkatmateti@gmail.com8152977460

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026